Duck Disease: Comprehensive Guide to Common Pathogens in Ducks

Introduction

Duck diseases represent a significant challenge to commercial waterfowl production, causing substantial economic losses through mortality, reduced growth performance, and trade restrictions [5, 18]. The term "duck disease" encompasses a broad spectrum of infectious and non-infectious conditions affecting domestic and wild ducks [6]. This guide provides a detailed, evidence-based review of the major bacterial and viral pathogens of ducks, with a focus on etiology, epidemiology, clinical signs, pathology, diagnostics, treatment, and control. Understanding the question "what is ducks disease" requires a systematic examination of the specific etiological agents that cause morbidity and mortality in duck populations [1, 5].

Bacterial Pathogens

Riemerella anatipestifer (New Duck Disease)

Riemerella anatipestifer is a Gram-negative, non-motile, rod-shaped bacterium that causes a septicemic disease known as New Duck disease, primarily in domestic ducks [2, 11]. The bacterium is a member of the family Flavobacteriaceae and is characterized by its fastidious growth requirements, typically cultured on blood agar or tryptic soy agar under microaerophilic conditions [11, 12].

Etiology and Epidemiology. R. anatipestifer is the causative agent of New Duck disease, a condition historically referred to as "duck septicemia" or "infectious serositis" [11]. The pathogen is highly contagious and spreads horizontally through direct contact, contaminated water, and fomites [2]. Outbreaks are most common in ducklings aged 2 to 7 weeks, with morbidity rates reaching 50% and mortality rates varying from 5% to 75% depending on the virulence of the strain and management conditions [12]. Genomic diversity among isolates has been documented, with molecular fingerprinting using ERIC-PCR revealing 10 to 12 bands per isolate ranging from 150 bp to 2000 bp, indicating substantial genetic variation among field strains [2]. Phylogenetic analysis of these fingerprints has shown that variants from commercial flocks are genetically more diverse compared to isolates from organized instructional farms [2].

Clinical Signs and Pathology. Affected ducklings present with acute onset of depression, ataxia, opisthotonos, and diarrhea [11, 12]. Postmortem examination typically reveals fibrinous pericarditis, perihepatitis, and airsacculitis, often accompanied by caseous exudate in the peritoneal cavity [11]. The bacterium can cross the blood-brain barrier, leading to meningitis [33]. The OmpA protein of R. anatipestifer has been identified as a key virulence factor mediating invasion of duck brain microvascular endothelial cells (DBMECs) and penetration of the duckling blood-brain barrier [33]. Specifically, amino acids 230-242 of OmpA represent a critical domain involved in this invasion process [33].

Diagnostics. Definitive diagnosis relies on bacterial isolation from liver, heart blood, or brain tissue, followed by biochemical identification or 16S rRNA gene sequencing [2, 11]. Species-specific PCR assays targeting the 16S rRNA gene provide rapid and sensitive detection, with 99% sequence similarity to the reference strain ATCC 11845 [2].

Treatment and Control. Antimicrobial therapy is guided by susceptibility testing, as resistance patterns vary geographically [11]. Control measures include strict biosecurity, all-in-all-out management, and vaccination with autogenous or commercial bacterins [5, 11].

Pasteurella multocida (Fowl Cholera)

Pasteurella multocida is a Gram-negative, bipolar-staining coccobacillus that causes fowl cholera, a highly contagious septicemic disease affecting ducks, chickens, and other avian species [18]. In ducks, the disease is often referred to as duck cholera and is the second most prevalent duck disease in some regions, with a reported prevalence of 28% in passive surveillance studies [18].

Etiology and Epidemiology. P. multocida serotypes A and D are most commonly associated with fowl cholera in ducks [18]. Transmission occurs via respiratory droplets, contaminated feed and water, and through carrier birds [5]. Outbreaks are more frequent in mature ducks, with one study reporting a higher frequency in young-aged ducks (33.96%) compared to mature birds, and no prevalence observed in birds aged above 269 days [18].

Clinical Signs and Pathology. Acute infections present with sudden death, fever, depression, and mucoid discharge from the mouth and nares [5]. Chronic infections may manifest as localized swelling of the wattles, sinuses, and joints [5]. Postmortem findings include petechial hemorrhages on the heart and serosal surfaces, hepatomegaly with multifocal necrosis, and splenomegaly [5].

Diagnostics. Diagnosis is confirmed by bacterial culture from blood, liver, or bone marrow, with Gram staining revealing characteristic bipolar staining [5]. Molecular methods, including species-specific PCR, are used for rapid detection and serotyping [24].

Treatment and Control. Antibiotics such as tetracyclines, sulfonamides, and fluoroquinolones are effective, though antimicrobial resistance is an emerging concern [5]. Vaccination with inactivated bacterins provides protection, and biosecurity measures are critical for prevention [5].

Salmonella enterica (Salmonellosis)

Salmonella enterica is a Gram-negative, facultative anaerobic rod that causes salmonellosis in ducks, with significant zoonotic implications [27]. Duck farms in eastern China have shown a significantly higher prevalence of Salmonella (19.17%) compared to chicken farms (6.61%) and pig farms (3.50%) [27].

Etiology and Epidemiology. Multiple serovars of S. enterica infect ducks, including S. Enteritidis, S. Typhimurium, and S. Indiana [8, 27]. The bacterium is shed in feces and can contaminate eggs, leading to vertical transmission [27]. Whole-genome sequencing of isolates from duck farms has revealed high rates of multidrug resistance (75.26%), with the highest resistance rates to tetracycline (76.20%) and ampicillin (67.62%) [27]. The most frequent serotype in one study was S. Kentucky (20.95%), which harbored more antimicrobial resistance patterns and genes than other serotypes [27].

Clinical Signs and Pathology. Clinical signs in ducklings include diarrhea, dehydration, depression, and increased mortality [8]. In older ducks, infection is often subclinical, but carriers can shed the bacterium intermittently [27]. Co-infection with other pathogens, such as duck reovirus, can exacerbate disease severity [8].

Diagnostics. Isolation of Salmonella from fecal samples, cloacal swabs, or tissues using selective media (e.g., MacConkey agar, XLD agar) is standard [27]. Serotyping and antimicrobial susceptibility testing are essential for epidemiological surveillance and treatment guidance [27]. Molecular methods, including PCR and whole-genome sequencing, provide high-resolution typing and resistance gene profiling [27].

Treatment and Control. Antimicrobial therapy should be based on susceptibility testing due to widespread resistance [27]. Control measures include biosecurity, all-in-all-out management, and monitoring of feed and water sources [5].

Escherichia coli (Colibacillosis)

Escherichia coli is a Gram-negative, facultative anaerobic rod that is a common cause of colibacillosis in ducks, often secondary to viral or environmental stressors [18]. Pathogenic strains of E. coli, particularly those with virulence factors such as fimbriae and toxins, can cause systemic disease [5].

Etiology and Epidemiology. Avian pathogenic E. coli (APEC) strains are associated with respiratory and septicemic disease in ducks [5]. Colibacillosis is frequently reported in passive surveillance studies, with prevalence rates varying by region and management system [18].

Clinical Signs and Pathology. Clinical signs include respiratory distress, depression, and diarrhea [5]. Postmortem findings include airsacculitis, pericarditis, perihepatitis, and fibrinous exudates in the coelomic cavity [5].

Diagnostics. Bacterial culture from affected tissues (liver, spleen, air sacs) on MacConkey agar yields lactose-fermenting colonies [5]. Serotyping and virulence gene profiling by PCR can differentiate APEC from commensal strains [5].

Treatment and Control. Antimicrobial therapy is guided by susceptibility testing [5]. Control relies on reducing environmental stressors, improving ventilation, and maintaining clean drinking water [5].

Clostridium botulinum Type C (Botulism)

Clostridium botulinum type C produces a potent neurotoxin that causes botulism in ducks, a condition historically known as "Western duck disease" [13]. The bacterium is a Gram-positive, spore-forming, obligate anaerobic rod [13].

Etiology and Epidemiology. Botulism in ducks is typically associated with the ingestion of preformed toxin in decaying organic matter, carcasses, or invertebrate larvae [13]. Outbreaks are often linked to warm, stagnant water conditions that favor bacterial growth and toxin production [13].

Clinical Signs and Pathology. Clinical signs include progressive flaccid paralysis of the legs, wings, and neck (limberneck), leading to respiratory failure and death [13]. Affected ducks are unable to hold their heads up and may drown if in water [13].

Diagnostics. Diagnosis is based on clinical signs, history of exposure, and detection of botulinum toxin in serum or gastrointestinal contents using a mouse bioassay or ELISA [13].

Treatment and Control. Treatment is supportive, with administration of type-specific antitoxin if available [13]. Control involves removal of carcasses, drainage of stagnant water, and prevention of access to decaying organic material [13].

Viral Pathogens

Duck Plague (Duck Viral Enteritis)

Duck plague, also known as duck viral enteritis (DVE), is caused by duck plague virus (DPV), a member of the family Herpesviridae, subfamily Alphaherpesvirinae [35]. DPV is a significant pathogen of ducks, geese, and swans, causing high morbidity and mortality [18]. In a retrospective study in Sylhet, Bangladesh, duck plague was the most prevalent duck disease, accounting for 45.3% of cases [18].

Etiology and Epidemiology. DPV is a double-stranded DNA virus with an envelope [35]. The virus is transmitted horizontally through direct contact, contaminated water, and fomites [5]. The UL49.5 protein of DPV, a homologue of glycoprotein N (gN), is involved in viral attachment, penetration, and cell-to-cell spread [35]. Deletion of UL49.5 results in attachment reduced to approximately 25% of the revertant virus and penetration ability reaching only 73% of the revertant virus [35]. The plaque sizes produced by UL49.5-deleted virus are approximately 58% smaller than those produced by the revertant virus [35].

Clinical Signs and Pathology. Clinical signs include sudden death, depression, anorexia, photophobia, and watery diarrhea [5]. Postmortem findings include hemorrhagic lesions on the mucosa of the esophagus, intestine, and cloaca, as well as petechial hemorrhages on the heart and liver [5]. The disease is more common in mature ducks, with one study reporting 66.20% prevalence in mature ducks compared to younger birds [18].

Diagnostics. Diagnosis is based on clinical signs, gross pathology, and histopathology [5]. Virus isolation in embryonated duck eggs or cell culture, followed by neutralization tests, is confirmatory [5]. PCR assays targeting DPV-specific genes are widely used for rapid detection [24].

Treatment and Control. There is no specific antiviral treatment for duck plague [5]. Control relies on vaccination with live attenuated vaccines and strict biosecurity measures [5].

Duck Viral Hepatitis (Duck Hepatitis A Virus)

Duck viral hepatitis (DVH) is a highly contagious, acute, and fatal disease of ducklings caused by Duck Hepatitis A virus (DHAV), a member of the family Picornaviridae, genus Avihepatovirus [3, 23]. The disease is characterized by neurological signs and liver enlargement with spot-like hemorrhages [23]. A proposed disease classification system for DVH has been developed to address the historical confusion caused by multiple hepatotropic viruses being associated with the same disease name [3]. This system, based on the nomenclature of human viral hepatitis and Koch's postulates, proposes 10 types of disease names to facilitate scientific communication [3].

Etiology and Epidemiology. DHAV is classified into three genotypes: DHAV-1, DHAV-2, and DHAV-3 [23, 31]. DHAV-1 and DHAV-3 are the most prevalent genotypes in Asia, while DHAV-2 has been reported in India [31]. The virus is highly contagious, spreading via the fecal-oral route, and causes high mortality in ducklings under 6 weeks of age [23]. In recent years, the mutation and recombination of epidemic strains, outbreaks of DHAV-3, and rising mixed infections have posed challenges to disease control [23].

Clinical Signs and Pathology. Affected ducklings present with opisthotonos, ataxia, and sudden death [23]. Postmortem findings include an enlarged, pale liver with petechial and ecchymotic hemorrhages, and a swollen, mottled spleen [23]. Histopathology reveals severe hepatocellular necrosis and inflammation [23].

Diagnostics. Diagnosis is based on clinical signs, gross pathology, and histopathology [23]. Virus isolation in embryonated duck eggs or cell culture is confirmatory [23]. Molecular methods, including RT-PCR and real-time RT-PCR, are widely used for rapid detection and genotyping [7, 15]. A triplex real-time PCR assay has been developed for simultaneous detection of DHAV-1, DHAV-3, and other duck viruses [7]. A multiplex RT-qPCR method using TaqMan probes has been developed for simultaneous detection of DHAV-1, DHAV-3, novel duck reovirus, and duck Tembusu virus, with detection limits of 6.03 x 10^1 and 1.88 x 10^2 copies/μL for DHAV-1 and DHAV-3, respectively [15]. Additionally, an RPA-CRISPR Cas12a/Cas13a one-pot strategy (DRCFS) has been developed for rapid detection of DHAV-3 and novel duck reovirus, with a detection limit of 100 copies/μL [17].

Treatment and Control. There is no specific antiviral treatment for DVH [23]. Control relies on vaccination with live attenuated or inactivated vaccines [23]. Passive immunization with yolk antibodies (IgY) has shown promise, with a dose of 0.5 mL per duckling (containing 64 mg/mL of IgY) significantly reducing DHAV-related mortality by 66% [14]. Selective breeding for resistance to DHAV-3 has been successful, with mortality rates reduced from 59.2% to 7.8% in a resistant line of Pekin ducks [34].

Duck Tembusu Virus (DTMUV)

Duck Tembusu virus (DTMUV) is an emerging pathogenic flavivirus that causes massive economic losses in the duck industry, particularly in China [7, 29]. The virus is transmitted by mosquitoes and causes a disease characterized by severe egg drop and neurological signs [7, 29].

Etiology and Epidemiology. DTMUV is a single-stranded, positive-sense RNA virus belonging to the family Flaviviridae, genus Flavivirus [29]. The virus is classified into multiple clusters, with Cluster 2 being prevalent in ducks and Cluster 3.2 emerging in chickens [32]. Chicken-origin Cluster 3.2 TMUV exhibits higher infectivity in chicks and ducklings compared to duck-origin Cluster 2 strains [32]. DTMUV is transmitted by mosquitoes and through direct contact [7].

Clinical Signs and Pathology. Clinical signs in laying ducks include a sudden drop in egg production, depression, anorexia, and neurological signs such as ataxia and tremors [29]. Postmortem findings include ovarian hemorrhage, follicular degeneration, and splenomegaly [29].

Diagnostics. Diagnosis is based on clinical signs, virus isolation in cell culture (e.g., chicken embryo fibroblasts), and molecular detection [7, 29]. A triplex real-time PCR assay has been developed for simultaneous detection of DTMUV, avian influenza virus, and Newcastle disease virus, with a detection limit of 1 x 10^1 copies/μL [7]. A multiplex digital PCR (dPCR) method has also been developed for simultaneous detection of DTMUV, duck circovirus, and new duck reovirus, with a detection limit of 1.3 copies/μL, which is 10 times higher than multiplex qPCR [26].

Treatment and Control. There is no specific antiviral treatment [29]. Control relies on vaccination with live attenuated vaccines, such as the FX2010-180P strain, which provides complete protection against virulent challenge [29]. Mosquito control and biosecurity measures are also important [7].

Newcastle Disease Virus (NDV)

Newcastle disease virus (NDV) is a member of the family Paramyxoviridae, genus Avulavirus, and causes Newcastle disease (ND) in a wide range of avian species [7, 30]. Ducks are generally considered natural reservoirs of NDV, but virulent strains can cause disease in ducks, particularly in young birds [30].

Etiology and Epidemiology. NDV is a single-stranded, negative-sense RNA virus classified into multiple genotypes [16, 21]. Ducks can carry velogenic strains without showing clinical signs, as demonstrated by the isolation of a genotype XVII strain from an apparently healthy domestic duck in Nigeria [16]. However, experimental infection of ducks with a duck-origin virulent NDV strain (JSD0812) has shown that susceptibility varies by breed, with mallard ducks being the most susceptible and Pekin ducks the most resistant [30]. Susceptibility decreases with age, with most deaths occurring in 15- and 30-day-old ducklings [30].

Clinical Signs and Pathology. Clinical signs in ducks include neurological signs such as ataxia, torticollis, and paralysis [30]. Postmortem findings may include hemorrhagic lesions in the proventriculus and intestine [30].

Diagnostics. Diagnosis is based on virus isolation in embryonated chicken eggs, hemagglutination inhibition (HI) tests, and molecular detection by RT-PCR [7, 30]. A triplex real-time PCR assay has been developed for simultaneous detection of NDV, avian influenza virus, and duck Tembusu virus [7].

Treatment and Control. There is no specific antiviral treatment [30]. Control relies on vaccination with live attenuated or inactivated vaccines [20]. A duck-origin NDV strain (NDRL0901) has been developed as a live vaccine candidate, providing significant protection efficacy (>80%) against very virulent NDV in chickens [20].

Duck Circovirus (DuCV)

Duck circovirus (DuCV) is a small, nonenveloped, single-stranded DNA virus with immunosuppressive effects on ducks [22, 25]. DuCV infection leads to slow growth, feather loss, and elevated mortality following mixed infections [22].

Etiology and Epidemiology. DuCV is a member of the family Circoviridae, genus Circovirus [22]. The virus has a circular genome of approximately 1995-1996 bp and contains three major open reading frames: ORFV1 (Rep protein), ORFC1 (Cap protein), and ORFC2 (apoptosis-related protein) [28]. DuCV is classified into two genotypes, with genotype I being further subdivided into sub-genotypes [25]. The virus is prevalent worldwide, with infection rates increasing in recent years [22]. In Thailand, DuCV isolates circulating belong to genotype I, with at least two sub-genotypes identified [25].

Clinical Signs and Pathology. Clinical signs include feather loss, emaciation, poor growth performance, and immunosuppression [22, 25]. Postmortem findings include atrophy of the bursa of Fabricius and spleen [25]. Co-infections with other pathogens, such as Riemerella anatipestifer, Escherichia coli, and duck Tembusu virus, are commonly observed due to the immunosuppressive effects of DuCV [25].

Diagnostics. Diagnosis is based on PCR detection of DuCV DNA in bursa of Fabricius or spleen samples [24, 25]. A quadruplex real-time quantitative PCR method has been developed for simultaneous detection of DuCV, Muscovy duck parvovirus, goose parvovirus, and duck adenovirus 3, with a detection limit of 1 copy/μL for DuCV [24].

Treatment and Control. There is no specific antiviral treatment [22]. Control relies on biosecurity measures and management practices to reduce stress and prevent co-infections [22]. Vaccines and antiviral therapies are under development [22].

Duck Reovirus (DRV)

Duck reovirus (DRV) is a member of the family Reoviridae, genus Orthoreovirus, and causes a range of diseases in ducks, including duck spleen necrosis disease (DSND) [8]. Novel duck reovirus (NDRV) is an emerging pathogen that causes substantial economic losses in the duck industry [15, 17].

Etiology and Epidemiology. DRV is a non-enveloped, double-stranded RNA virus with a segmented genome consisting of 10 segments [8]. The genome of a DRV strain (DRV/GX-Y7) isolated from DSND cases was 23,418 bp in length, with segments ranging from 3959 nt (L1) to 1191 nt (S4) [8]. Phylogenetic analysis showed that this strain belongs to a new waterfowl-origin reovirus cluster, distinct from Muscovy duck reovirus (MDRV) and goose-origin reovirus (GRV) [8]. Genetic reassortment events have been identified in the M2 and S1 segments [8].

Clinical Signs and Pathology. Clinical signs of DSND include depression, anorexia, and sudden death [8]. Postmortem findings include severe hemorrhagic and/or necrotic lesions in the immune organs (thymus, spleen, and bursae) [8]. Co-infection with Salmonella indiana can greatly enhance pathogenesis, increasing morbidity and mortality [8].

Diagnostics. Diagnosis is based on virus isolation in cell culture (e.g., Vero, LMH, DF-1, and DEF cells) and molecular detection by RT-PCR [8, 15]. A multiplex RT-qPCR method has been developed for simultaneous detection of NDRV, DHAV-1, DHAV-3, and DTMUV, with a detection limit of 1.24 x 10^2 copies/μL for NDRV [15]. An RPA-CRISPR Cas12a/Cas13a one-pot strategy (DRCFS) has also been developed for rapid detection of NDRV and DHAV-3, with a detection limit of 100 copies/μL [17].

Treatment and Control. There is no specific antiviral treatment [8]. Control relies on biosecurity measures and management practices to prevent co-infections [8].

Other Viral Pathogens

Other viral pathogens affecting ducks include Muscovy duck parvovirus (MDPV), goose parvovirus (GPV), and duck adenovirus 3 (DAdV-3) [24]. These viruses can cause significant morbidity and mortality, particularly in young birds [24]. A quadruplex real-time quantitative PCR method has been developed for simultaneous detection of MDPV, GPV, DuCV, and DAdV-3, with detection limits of 10, 10, 1, and 10 copies/μL, respectively [24].

Diagnostic Approaches

Diagnostic approaches for duck diseases include clinical examination, gross pathology, histopathology, virus isolation, bacterial culture, serology, and molecular methods [5, 7, 15]. Molecular methods, including PCR, real-time PCR, digital PCR, and CRISPR-based assays, offer high sensitivity and specificity for rapid detection of pathogens [7, 15, 17, 26]. Multiplex assays allow simultaneous detection of multiple pathogens, which is particularly important given the high prevalence of co-infections in duck populations [7, 15, 24, 26].

flowchart TD
    A[Clinical Signs in Ducks], > B{Initial Assessment}
    B, > C[Neurological Signs]
    B, > D[Respiratory Signs]
    B, > E[Digestive Signs]
    B, > F[Egg Drop]
    C, > G[Suspect DHAV, NDV, or Botulism]
    D, > H[Suspect Fowl Cholera or Colibacillosis]
    E, > I[Suspect Duck Plague or Salmonellosis]
    F, > J[Suspect DTMUV or NDV]
    G, > K[Collect Brain, Liver, Serum]
    H, > K[Collect Lung, Air Sac, Liver]
    I, > K[Collect Intestine, Liver, Feces]
    J, > K[Collect Ovarian Tissue, Cloacal Swab]
    K, > L{Laboratory Diagnostics}
    L, > M[Bacterial Culture & Sensitivity]
    L, > N[Virus Isolation in Eggs/Cells]
    L, > O[Molecular Detection: PCR, qPCR, dPCR]
    L, > P[Serology: HI, ELISA]
    M, > Q[Identify Bacterial Pathogen]
    N, > R[Identify Viral Pathogen]
    O, > S[Confirm Pathogen & Genotype]
    P, > T[Detect Antibodies]
    Q, > U[Antimicrobial Therapy]
    R, > U[Supportive Care & Vaccination]
    S, > U[Targeted Control Measures]
    T, > U[Vaccination & Biosecurity]

Treatment and Control

Treatment of bacterial infections in ducks is guided by antimicrobial susceptibility testing due to widespread resistance [5, 27]. For viral infections, there are no specific antiviral treatments, and control relies on vaccination, biosecurity, and management practices [5, 23]. Vaccination with live attenuated or inactivated vaccines is effective for many viral diseases, including duck plague, duck viral hepatitis, and duck Tembusu virus disease [5, 23, 29]. Selective breeding for disease resistance has shown promise for DHAV-3 [34]. Passive immunization with yolk antibodies (IgY) is an emerging strategy for DHAV [14].

Control measures include strict biosecurity, all-in-all-out management, proper sanitation, and vector control [5, 22]. Surveillance and early detection using molecular diagnostics are critical for preventing outbreaks [7, 15, 17, 26].

References

[1] Muscovy duck disease. CABI Compendium. 2022. URL: https://www.semanticscholar.org/paper/48a5c202658e875cdd15da377dc4b443c0f85508

[2] Pala S, Radhakrishnan U. Genomic diversity of Riemerella anatipestifer associated with outbreaks of New Duck disease in India. Indian Journal of Animal

[3] Ou X, Mao S, Dong J, et al. A proposed disease classification system for duck viral hepatitis. Poultry Science. 2022. URL: https://www.semanticscholar.org/paper/cc613f393c6cfdac38c6f4b71509f1d28c15767e

[4] González N. Detection and Molecular Characterization of Duck Disease. 2020. URL: https://www.semanticscholar.org/paper/241d36ea6ad3400dc54077b6bef856a442a35ea7